Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
July 31, 2006
Study Completion Date
February 28, 2007
Conditions
Healthy SubjectsOsteoarthritis
Interventions
DRUG
AGG-523
Trial Locations (1)
19148
Philadelphia
All Listed Sponsors
lead
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
NCT00380900 - Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy | Biotech Hunter | Biotech Hunter